Login
Home
Charts
Search
Watchlist
Products

Sharat Industries Ltd

SHINDL·BSE
165.90+2.22%Wed, 23 Sept '26 15:29

Sharat Industries Ltd

SHINDL
BSE
165.90
+2.22%
|Wed, 23 Sept '26 15:29
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
651Cr
Close
Close Price
165.90
Industry
Industry
Aquaculture
PE
Price To Earnings
38.76
PS
Price To Sales
1.23
Revenue
Revenue
530Cr
Rev Gr TTM
Revenue Growth TTM
30.53%
PAT Gr TTM
PAT Growth TTM
37.00%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
976165901009694115150143117120
Growth YoY
Revenue Growth YoY%
-1.4-28.83.312.43.658.845.228.249.247.824.84.4
Expenses
ExpensesCr
90566182918990104138133114107
Operating Profit
Operating ProfitCr
7547984111210313
OPM
OPM%
7.47.75.58.29.28.14.49.88.06.72.810.8
Other Income
Other IncomeCr
000000100210
Interest Expense
Interest ExpenseCr
322233333333
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
410454178709
Tax
TaxCr
100121022203
PAT
PATCr
310343156506
Growth YoY
PAT Growth YoY%
64.3-49.728.670.032.7190.147.275.553.979.5-90.616.9
NPM
NPM%
2.91.50.63.43.72.70.64.73.83.30.05.2
EPS
EPS
0.90.30.11.01.61.10.11.41.51.20.01.6
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
976165901009694115150143117120
Growth YoY
Revenue Growth YoY%
-1.4-28.83.312.43.658.845.228.249.247.824.84.4
Expenses
ExpensesCr
90566182918990104138133114107
Operating Profit
Operating ProfitCr
7547984111210313
OPM
OPM%
7.47.75.58.29.28.14.49.88.06.72.810.8
Other Income
Other IncomeCr
000000100210
Interest Expense
Interest ExpenseCr
322233333333
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
410454178709
Tax
TaxCr
100121022203
PAT
PATCr
310343156506
Growth YoY
PAT Growth YoY%
64.3-49.728.670.032.7190.147.275.553.979.5-90.616.9
NPM
NPM%
2.91.50.63.43.72.70.64.73.83.30.05.2
EPS
EPS
0.90.30.11.01.61.10.11.41.51.20.01.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2013Mar 2014Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
60139247333302381525530
Growth
Revenue Growth%
131.234.6-9.125.937.930.5
Expenses
ExpensesCr
55131234314281352489492
Operating Profit
Operating ProfitCr
58131821293638
OPM
OPM%
8.25.65.45.57.07.56.97.1
Other Income
Other IncomeCr
00131233
Interest Expense
Interest ExpenseCr
00699111212
Depreciation
DepreciationCr
33445555
PBT
PBTCr
25598142324
Tax
TaxCr
00132477
PAT
PATCr
25376101617
Growth
PAT Growth%
201.387.8-9.669.659.637.0
NPM
NPM%
2.53.31.41.91.92.63.03.2
EPS
EPS
1.52.11.93.04.14.3
Financial YearMar 2013Mar 2014Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
60139247333302381525530
Growth
Revenue Growth%
131.234.6-9.125.937.930.5
Expenses
ExpensesCr
55131234314281352489492
Operating Profit
Operating ProfitCr
58131821293638
OPM
OPM%
8.25.65.45.57.07.56.97.1
Other Income
Other IncomeCr
00131233
Interest Expense
Interest ExpenseCr
00699111212
Depreciation
DepreciationCr
33445555
PBT
PBTCr
25598142324
Tax
TaxCr
00132477
PAT
PATCr
25376101617
Growth
PAT Growth%
201.387.8-9.669.659.637.0
NPM
NPM%
2.53.31.41.91.92.63.03.2
EPS
EPS
1.52.11.93.04.14.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2424243839
Reserves
ReservesCr
46556099115
Current Liabilities
Current LiabilitiesCr
96101105129126
Non Current Liabilities
Non Current LiabilitiesCr
1918151336
Total Liabilities
Total LiabilitiesCr
186198204279316
Current Assets
Current AssetsCr
130140149227259
Non Current Assets
Non Current AssetsCr
5658555257
Total Assets
Total AssetsCr
186198204279316
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2424243839
Reserves
ReservesCr
46556099115
Current Liabilities
Current LiabilitiesCr
96101105129126
Non Current Liabilities
Non Current LiabilitiesCr
1918151336
Total Liabilities
Total LiabilitiesCr
186198204279316
Current Assets
Current AssetsCr
130140149227259
Non Current Assets
Non Current AssetsCr
5658555257
Total Assets
Total AssetsCr
186198204279316

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
217-2-261
Investing Cash Flow
Investing Cash FlowCr
-8-6-2-2-9
Financing Cash Flow
Financing Cash FlowCr
9-7-4483
Net Cash Flow
Net Cash FlowCr
34-720-5
Free Cash Flow
Free Cash FlowCr
217-2-261
CFO To PAT
CFO To PAT%
52.6266.8-28.3-258.39.2
CFO To EBITDA
CFO To EBITDA%
13.594.0-7.9-90.14.0
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
217-2-261
Investing Cash Flow
Investing Cash FlowCr
-8-6-2-2-9
Financing Cash Flow
Financing Cash FlowCr
9-7-4483
Net Cash Flow
Net Cash FlowCr
34-720-5
Free Cash Flow
Free Cash FlowCr
217-2-261
CFO To PAT
CFO To PAT%
52.6266.8-28.3-258.39.2
CFO To EBITDA
CFO To EBITDA%
13.594.0-7.9-90.14.0

Ratios

Consolidated
Standalone
Financial YearMar 2013Mar 2014Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
141109101282576651
Price To Earnings
Price To Earnings
40.516.717.228.336.238.8
Price To Sales
Price To Sales
0.60.30.30.71.11.2
Price To Book
Price To Book
2.01.41.22.13.74.2
EV To EBITDA
EV To EBITDA
16.710.19.112.918.919.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.819.417.519.5
OPM
OPM%
8.25.65.45.57.07.56.97.1
NPM
NPM%
2.53.31.41.91.92.63.03.2
ROCE
ROCE%
6.710.59.510.212.212.2
ROE
ROE%
4.98.37.07.310.310.3
ROA
ROA%
1.93.32.93.65.05.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2013Mar 2014Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
141109101282576651
Price To Earnings
Price To Earnings
40.516.717.228.336.238.8
Price To Sales
Price To Sales
0.60.30.30.71.11.2
Price To Book
Price To Book
2.01.41.22.13.74.2
EV To EBITDA
EV To EBITDA
16.710.19.112.918.919.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.819.417.519.5
OPM
OPM%
8.25.65.45.57.07.56.97.1
NPM
NPM%
2.53.31.41.91.92.63.03.2
ROCE
ROCE%
6.710.59.510.212.212.2
ROE
ROE%
4.98.37.07.310.310.3
ROA
ROA%
1.93.32.93.65.05.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
- **Sharat Industries is India’s oldest integrated shrimp company, built from a single entrepreneur’s bet on a new species that revived an entire industry. Incorporated as Sharat Sea Foods and initiating farm operations in 1990, it transformed after a devastating virus outbreak by building its own feed mill and processing plant, then commercialised the Vannamei shrimp that its founder had introduced to Indian waters. The recurring approach is vertical integration on a single coastal campus - hatchery, feed, farm and plant within five kilometres of each other - so the company controls quality from seedling to shipment and captures margin at every step.** # Business segments Two engines feed one export machine - a shrimp feed business that supplies its own farms and outside growers, and a processing plant that freezes and ships everything the company can source, with a captive farm acting as the quality anchor between them. ## 1. Shrimp feed: the nutrition engine that locks in supply **A captive mill making 20,000-plus tonnes of feed a year supplies the company’s own ponds and a network of external farmers, cutting the single biggest farm cost while pulling shrimp back into the processing plant.** - **Feed is half the farm cost** - raw material alone represents roughly 50% of what it costs to grow a crop, so making feed in-house rather than buying it from a third party directly improves margins on every tonne of company-farmed shrimp. - **A buyback loop that feeds the plant** - external farmers who buy the company’s feed can sell their harvest back to the processing division under a material-buyback arrangement, which gives the plant access to more shrimp without owning more ponds. - **R&D is chasing cheaper protein** - pilot projects are already testing insect protein as a substitute for fish meal, aiming to lower the cost of the single most expensive ingredient while keeping the feed nutritionally effective. ## 2. Shrimp processing and export: the revenue engine that reaches 25-plus countries **A 7,500-tonne-capacity freezing plant turns raw shrimp into over 17 product forms for buyers across Russia, the US, China and Europe, generating roughly two-thirds to 80% of the company’s revenue.** - **Russia is the anchor market** - the company is among the top three Indian exporters of shrimp to Russia by volume and holds one of the few Russia-approved processing licences in the country, a regulatory moat that limits competition for that demand. - **Three ways to fill the plant** - shrimp comes from the company’s own farm, from 55-plus contract farmers who get seed, feed and technical support, and from merchant-export job work done for other processors, so utilisation stays high even when harvests fluctuate. - **Value-added products lift the mix** - while most output is raw frozen shrimp in forms like head-on shell-on and peeled deveined tail-off, cooked and blanched lines contributed 5% of volumes in FY25, and a new “PD - Curl Control” product was added in early 2026. - **Certifications open doors** - the plant carries BRC A-grade, BAP 4-star, EU approval, FDA registration and FSSC 22000, among others, which means it can ship to the most demanding regulators and switch between geographies as demand shifts. - **Domestic sales are just beginning** - the company started supplying raw frozen shrimp to Zomato Hyperpure in early 2026 and plans to build a domestic frozen-shrimp business through the HoReCa (hotel, restaurant and catering) channel first, then retail. ## 3. Own farming: the quality anchor and disease-fighting laboratory **A 500-acre coastal farm with 2,000 tonnes of annual capacity produces antibiotic-free shrimp that sets the quality standard for the processing plant, while doubling as a test bed for biosecurity and feeding trials.** - **Seawater on tap** - the farm sits directly on the Bay of Bengal with interlocking canals that deliver uninterrupted seawater, plus bore wells to fine-tune salinity, so water parameters stay optimal without relying on external sources. - **Running lean to stay safe** - the farm operated at roughly 50% of capacity in FY25, a deliberate choice to manage disease risk rather than chase volume, after heavy capital investment in infrastructure designed to reduce shrimp mortality. - **The plant’s captive supply** - back-to-back crops yielded about 800 tonnes, covering roughly 15% of the processing plant’s raw-material needs, which gives the export business a guaranteed base load of fully traceable, in-house shrimp. # Group structure and partners **The company runs as a single integrated operation, with a joint-venture farm vehicle and a promoter family that has steered the business since its trawler-licence days.** - **One reportable segment** - despite operating feed, farm and processing divisions, the company reports as a single integrated aquaculture business, reflecting how tightly the pieces depend on one another. - **A joint-venture farm next door** - United Aquatech Private Limited, a special-purpose vehicle in Nellore, is 49%-owned by Sharat Industries and was set up in 2022 with UAL Biotech to expand farming capacity and productivity. - **Founder-led board** - Mr. Prasad Reddy Sabbella, who introduced Vannamei shrimp to India, serves as Managing Director alongside his son Mr. Sharat Reddy Sabbella as Executive Director, with independent directors rounding out the board. - **Listed, with a recent rights issue** - the company’s shares trade on the BSE, and a rights issue in mid-2024 raised fresh capital by offering shares at ₹31 apiece in a 13-for-20 ratio to existing shareholders.

Documents — Sharat Industries Ltd

  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/q8atyohl6syd6bw6habkwn7t.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/bcuc1u9rusfiw8g88zlpinjx.pdf
  • Q4 FY2023 Earnings Call Transcript (Mar 2023, PDF): https://www.stockscans.in/document/6haesk8ze56ke0a0u6gne46o.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/mhmy5bctzkz385si1t1po2p4.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/39oxxa9sfrmuh3t4lnu05yu4.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/08co7cdz69pa3yu50o5sry29.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/qmmiap2hgb3s1it9zxmrziwl.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/js46m7fivwv6g2f9atbufodl.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/smahe9ji845t16u60mrncu85.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/sxz7bnz4h5qmf2l9d4ra99p5.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/wqladle8lqteudmnvj5egx5n.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/de492dt4s6apno2fg93q63st.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/foevsada36oynndg1m8b029w.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/7viiql8e8yhrx2pqii7jfghz.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/4vq1qw9mwpo954p0gy2en0b0.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/wkff9js0c5qdyf7z01honqg7.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/5f3gj1qqkhl8vsqypnqmpf24.pdf
  • Q4 FY2024 Investor Presentation (Mar 2024, PDF): https://www.stockscans.in/document/zj6v25vc6a03h7n3zchoz56o.pdf
  • Q3 FY2024 Investor Presentation (Dec 2023, PDF): https://www.stockscans.in/document/nzoxvhw45iqr6vbg3yto8ky5.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/ouw3misdsyeld37u3tclsrl7.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/dtgua0zvi6givm6a6kz4szyu.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/drr7wcj8cn0ouimx5alumly5.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/r519g7jd695l893xnajcm9c9.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/qikd6csi6djat594r99omj9y.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/puq6yy4f4jpxjw5mlfq5m3pj.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/xakx2klih2cr9zg5ctft7lhh.pdf
  • FY2016 Annual Report (PDF): https://www.stockscans.in/document/bxc6yf76ilh1d5pi0pmus0x8.pdf

Concall Transcript Summaries — Sharat Industries Ltd

  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/BSE%3ASHINDL/transcript-notes/202603/q8atyohl6syd6bw6habkwn7t.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/BSE%3ASHINDL/transcript-notes/202512/bcuc1u9rusfiw8g88zlpinjx.pdf
  • Q4 FY2023 Concall Transcript Summary (Mar 2023): https://www.stockscans.in/company/BSE%3ASHINDL/transcript-notes/202303/6haesk8ze56ke0a0u6gne46o.pdf